These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22936102)
21. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Ahmed AO; van de Sande WW; van Vianen W; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA Antimicrob Agents Chemother; 2004 Jul; 48(7):2742-6. PubMed ID: 15215141 [TBL] [Abstract][Full Text] [Related]
22. Role for cell density in antifungal drug resistance in Candida albicans biofilms. Perumal P; Mekala S; Chaffin WL Antimicrob Agents Chemother; 2007 Jul; 51(7):2454-63. PubMed ID: 17502416 [TBL] [Abstract][Full Text] [Related]
23. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp. da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328 [TBL] [Abstract][Full Text] [Related]
24. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species. Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364 [TBL] [Abstract][Full Text] [Related]
25. Antifungal and Anti-Biofilm Activity of Essential Oil Active Components against Kumari P; Mishra R; Arora N; Chatrath A; Gangwar R; Roy P; Prasad R Front Microbiol; 2017; 8():2161. PubMed ID: 29163441 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department. Touil HFZ; Boucherit-Otmani Z; Boucherit K J Mycol Med; 2018 Sep; 28(3):414-418. PubMed ID: 30032993 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex. Cordeiro RA; Evangelista AJJ; Serpa R; Marques FJF; Melo CVS; Oliveira JS; Franco JDS; Alencar LP; Bandeira TJPG; Brilhante RSN; Sidrim JJC; Rocha MFG Microbiology (Reading); 2016 Feb; 162(2):309-317. PubMed ID: 26645478 [TBL] [Abstract][Full Text] [Related]
28. Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms. Luiz RL; Vila TV; de Mello JC; Nakamura CV; Rozental S; Ishida K BMC Complement Altern Med; 2015 Mar; 15():68. PubMed ID: 25886244 [TBL] [Abstract][Full Text] [Related]
29. Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cryptococcus species and literature review. Bernal-Martinez L; Gomez-Lopez A; Castelli MV; Mesa-Arango AC; Zaragoza O; Rodriguez-Tudela JL; Cuenca-Estrella M Med Mycol; 2010 Feb; 48(1):90-6. PubMed ID: 19235546 [TBL] [Abstract][Full Text] [Related]
30. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints]. Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300 [TBL] [Abstract][Full Text] [Related]
31. Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil. Ferreira-Paim K; Andrade-Silva L; Mora DJ; Lages-Silva E; Pedrosa AL; da Silva PR; Andrade AA; Silva-Vergara ML Mycopathologia; 2012 Jul; 174(1):41-52. PubMed ID: 22116628 [TBL] [Abstract][Full Text] [Related]
32. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms]. Valentín A; Cantón E; Pemán J; Quindós G Rev Iberoam Micol; 2007 Dec; 24(4):272-7. PubMed ID: 18095759 [TBL] [Abstract][Full Text] [Related]
33. In vitro Antifungal Activity of a Novel Antimicrobial Peptide AMP-17 Against Planktonic Cells and Biofilms of Yang L; Tian Z; Zhou L; Zhu L; Sun C; Huang M; Peng J; Guo G Infect Drug Resist; 2022; 15():233-248. PubMed ID: 35115792 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the antifungal effect of EDTA, a metal chelator agent, on Candida albicans biofilm. Casalinuovo IA; Sorge R; Bonelli G; Di Francesco P Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1413-1420. PubMed ID: 28387883 [TBL] [Abstract][Full Text] [Related]
35. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains. Xia J; Qian F; Xu W; Zhang Z; Wei X Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391 [TBL] [Abstract][Full Text] [Related]
36. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. Jafri H; Ahmad I J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964 [TBL] [Abstract][Full Text] [Related]
37. Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B. de Aguiar Cordeiro R; Mourão CI; Rocha MF; de Farias Marques FJ; Teixeira CE; de Oliveira Miranda DF; Neto LV; Brilhante RS; de Jesus Pinheiro Gomes Bandeira T; Sidrim JJ Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):557-64. PubMed ID: 23192488 [TBL] [Abstract][Full Text] [Related]
38. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B. Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765 [TBL] [Abstract][Full Text] [Related]
39. In vitro inhibitory activities of magnolol against Zhou P; Fu J; Hua H; Liu X Drug Des Devel Ther; 2017; 11():2653-2661. PubMed ID: 28919715 [No Abstract] [Full Text] [Related]
40. [Architecture, influencing factors, and sensitivity to antifungal agents of Candida biofilm]. Sun QN; Fang K Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):385-8. PubMed ID: 12905659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]